Skip to content

Nursing Consultation in Out-patient Clinics for Patients With Inflammatory Rheumatic Disease

Nursing Consultation in Out-patient Clinics for Patients With Inflammatory Rheumatic Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00403676
Enrollment
68
Registered
2006-11-27
Start date
2005-09-30
Completion date
2008-08-31
Last updated
2012-06-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthritis

Keywords

nurse practitioner, rheumatology care, outpatient clinic, patient satisfaction

Brief summary

Evaluate the effectiveness and acceptability of care given by nurse specialists in out patient clinics, through a randomized controlled study.

Detailed description

This study is part of a national multicenter study (NOR-DMARD) that aims to measure the longterm safety and effectiveness of disease modifying therapies in inflammatory arthropathies. The Nor-Dmard study is a comparative, phase IV, longitudinal, observational study. All patients starting a DMARD regime are enrolled. Patients from two clinics (different parts of Norway) will be randomised to receive follow-up care from either a clinical nurse or a rheumatologist. The primary outcome measure is patient satisfaction measured by Leeds Satisfaction Questionnaire. The secondary outcome is effectiveness measured by Coping (CORS),Health related quality of life (SF-36) and Disease activity (MHAQ, DAS-28).

Interventions

OTHERFollow up bu a nurse

Follow up bu a nurse

OTHERFollow up by a medical doctor

Follow up by a medical doctor

Sponsors

St. Olavs Hospital
CollaboratorOTHER
Diakonhjemmet Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with inflammatory arthropathies monitored after starting disease modifying antirheumatic drugs.

Design outcomes

Primary

MeasureTime frame
patient satisfaction12 mnths and 24 mnths

Secondary

MeasureTime frame
Health related quality of life12 mnths and 24 mnths
Disease activity12 mnths and 24 mnths
coping12 mnths and 24 mnths

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 24, 2026